- Home
- PRMB vs EXEL Comparison
PRMB vs EXEL Comparison
Compare PRMB & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRMB
- EXEL
- Stock Information
- Founded
- PRMB 1955
- EXEL 1994
- Country
- PRMB United States
- EXEL United States
- Employees
- PRMB N/A
- EXEL N/A
- Industry
- PRMB
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRMB
- EXEL Health Care
- Exchange
- PRMB Nasdaq
- EXEL Nasdaq
- Market Cap
- PRMB 10.7B
- EXEL 12.0B
- IPO Year
- PRMB N/A
- EXEL 2000
- Fundamental
- Price
- PRMB $24.11
- EXEL $37.41
- Analyst Decision
- PRMB Strong Buy
- EXEL Buy
- Analyst Count
- PRMB 10
- EXEL 21
- Target Price
- PRMB $40.30
- EXEL $44.00
- AVG Volume (30 Days)
- PRMB 6.1M
- EXEL 3.7M
- Earning Date
- PRMB 08-07-2025
- EXEL 07-28-2025
- Dividend Yield
- PRMB 1.64%
- EXEL N/A
- EPS Growth
- PRMB N/A
- EXEL 81.76
- EPS
- PRMB N/A
- EXEL 2.08
- Revenue
- PRMB $6,046,100,000.00
- EXEL $2,230,005,000.00
- Revenue This Year
- PRMB $37.86
- EXEL $9.88
- Revenue Next Year
- PRMB $4.08
- EXEL $12.59
- P/E Ratio
- PRMB N/A
- EXEL $18.16
- Revenue Growth
- PRMB 26.25
- EXEL 10.73
- 52 Week Low
- PRMB $22.64
- EXEL $25.12
- 52 Week High
- PRMB $35.85
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- PRMB N/A
- EXEL 35.96
- Support Level
- PRMB N/A
- EXEL $37.10
- Resistance Level
- PRMB N/A
- EXEL $38.09
- Average True Range (ATR)
- PRMB 0.00
- EXEL 1.26
- MACD
- PRMB 0.00
- EXEL -0.39
- Stochastic Oscillator
- PRMB 0.00
- EXEL 14.50
About PRMB Primo Brands Corporation Class A Common Stock
Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.